MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3324/haematol.2015.130179

Медицинская библиотека · Haematologica · 2015

Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.

Vicente Carmen, Schwab Claire, Broux Michaël, Geerdens Ellen, Degryse Sandrine, Demeyer Sofie, Lahortiga Idoya, Elliott Alannah, Chilton Lucy, La Starza Roberta, Mecucci Cristina, Vandenberghe Peter, Goulden Nicholas, Vora Ajay, Moorman Anthony V, Soulier Jean, Harrison Christine J, Clappier Emmanuelle, Cools Jan

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

T-cell acute lymphoblastic leukemia is caused by the accumulation of multiple oncogenic lesions, including chromosomal rearrangements and mutations. To determine the frequency and co-occurrence of mutations in T-cell acute lymphoblastic leukemia, we performed targeted re-sequencing of 115 genes across 155 diagnostic samples (44 adult and 111 childhood cases). NOTCH1 and CDKN2A/B were mutated/deleted in more than half of the cases, while an additional 37 genes were mutated/deleted in 4% to 20% of cases. We found that IL7R-JAK pathway genes were mutated in 27.7% of cases, with JAK3 mutations being the most frequent event in this group. Copy number variations were also detected, including deletions of CREBBP or CTCF and duplication of MYB. FLT3 mutations were rare, but a novel extracellular mutation in FLT3 was detected and confirmed to be transforming. Furthermore, we identified complex patterns of pairwise associations, including a significant association between mutations in IL7R-JAK genes and epigenetic regulators (WT1, PRC2, PHF6). Our analyses showed that IL7R-JAK genetic lesions did not confer adverse prognosis in T-cell acute lymphoblastic leukemia cases enrolled in the UK ALL2003 trial. Overall, these results identify interconnections between the T-cell acute lymphoblastic leukemia genome and disease biology, and suggest a potential clinical application for JAK inhibitors in a significant proportion of patients with T-cell acute lymphoblastic leukemia.

Для цитирования: Vicente Carmen, Schwab Claire, Broux Michaël, Geerdens Ellen, Degryse Sandrine, Demeyer Sofie, Lahortiga Idoya, Elliott Alannah, Chilton Lucy, La Starza Roberta, Mecucci Cristina, Vandenberghe Peter, Goulden Nicholas, Vora Ajay, Moorman Anthony V, Soulier Jean, Harrison Christine J, Clappier Emmanuelle, Cools Jan. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.. Haematologica. 2015. DOI: 10.3324/haematol.2015.130179.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.